Back to Authors

Butterfield, JH

Mayo Clinic

Mayo Clinic

Citations 2

Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia
Butterfield, JH, Leiferman, KM, Abrams, J S, Silver, JE, Bower, James H., Gonchoroff, Nick J., Gleich, GJ

Blood | October 13, 2019 | Volume: 79 | Issue: 3 | Pages: 688-692

10.1182/blood.v79.3.688.688 Get It

Abstract The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the percentage of activated T cells in the peripheral blood of a new patient before and during an attack. In the patient presented, IL-5 levels peaked several days before maximal eosinophilia and then declined. This patient's lymphocytes showed an increased percentage, 28% (normal 2% to 3%), of activated T cells staining for both CD3 and HLA-DR 10 days before maximal eosinophilia, but no increase at the time of peak eosinophilia. In serum from three previously reported cases, elevated serum IL-5 levels were found during attacks. After glucocorticoid administration, IL-5 levels became undetectable in three of the four patients. Production of IL-5 is likely an important determinant of the pathophysiology of this syndrome.
Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia
Butterfield, JH, Leiferman, KM, Abrams, J S, Silver, JE, Bower, James H., Gonchoroff, Nick J., Gleich, GJ

Blood | October 13, 2019 | Volume: 79 | Issue: 3 | Pages: 688-692

10.1182/blood.v79.3.688.bloodjournal793688 Get It

The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the percentage of activated T cells in the peripheral blood of a new patient before and during an attack. In the patient presented, IL-5 levels peaked several days before maximal eosinophilia and then declined. This patient's lymphocytes showed an increased percentage, 28% (normal 2% to 3%), of activated T cells staining for both CD3 and HLA-DR 10 days before maximal eosinophilia, but no increase at the time of peak eosinophilia. In serum from three previously reported cases, elevated serum IL-5 levels were found during attacks. After glucocorticoid administration, IL-5 levels became undetectable in three of the four patients. Production of IL-5 is likely an important determinant of the pathophysiology of this syndrome.